Home › Funds › Trails Edge Capital Partners, LP › CTNM
Trails Edge Capital Partners, LP position in CTNM
CONTINEUM THERAPEUTICS INC · Health Care
Trails Edge Capital Partners, LP reported holding 1,693,694 shares of CTNM (CONTINEUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$22.7M, representing 3.27% of its reported portfolio and ranking #15 among its reported holdings. Trails Edge Capital Partners, LP first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Trails Edge Capital Partners, LP's CTNM position evolved
Trails Edge Capital Partners, LP first disclosed a stake in CTNM in Q3 2026 at 1,693,694 shares (US$22.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.69M | $22.73M | New |
About CTNM and 13F data
CTNM (CONTINEUM THERAPEUTICS INC) is a Health Care company. 58 other funds we track also report a position in CTNM — the largest reported positions include MONTANOVA CAPITAL, LLC (US$46.6M), JOHNSON & JOHNSON (US$26.6M), Versant Venture Management, LLC (US$17.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CTNM
- MONTANOVA CAPITAL, LLC 2.84M sh · $46.57M · Q2 2026
- JOHNSON & JOHNSON 1.98M sh · $26.56M · Q3 2026
- Versant Venture Management, LLC 1.29M sh · $17.35M · Q3 2026
- GREAT POINT PARTNERS LLC 921.48K sh · $15.10M · Q2 2026
- Ikarian Capital, LLC 807.87K sh · $13.24M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 669.34K sh · $10.97M · Q2 2026
- SECTORAL ASSET MANAGEMENT INC 689.59K sh · $9.25M · Q3 2026
- Red Tree Management, LLC 638.16K sh · $8.56M · Q3 2026
- Boxer Capital Management, LLC 494.00K sh · $8.10M · Q2 2026
- Squadron Capital Management LLC 260.00K sh · $4.26M · Q2 2026
- HighVista Strategies LLC 217.79K sh · $2.92M · Q3 2026
- Casdin Capital 148.33K sh · $2.43M · Q2 2026
More on Trails Edge Capital Partners, LP
FAQ
How long has Trails Edge Capital Partners, LP held CTNM?
Trails Edge Capital Partners, LP has disclosed CTNM holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Trails Edge Capital Partners, LP's current position in CTNM?
As of Q3 2026, Trails Edge Capital Partners, LP holds 1.69M shares of CTNM (CONTINEUM THERAPEUTICS INC), valued at $22.73M, representing 3.27% of its reported portfolio and ranking #15.
Has Trails Edge Capital Partners, LP been buying or selling CTNM?
In the latest 13F filing (Q3 2026), Trails Edge Capital Partners, LP newly opened its position in CTNM.
Which other funds hold CTNM?
Other major institutional holders of CTNM include MONTANOVA CAPITAL, LLC, JOHNSON & JOHNSON, Versant Venture Management, LLC, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.